rec. | Subject | Hit Length | Description | Align.Len | E value | Bit score | % ident. | % pos. | GO associations |
481 | Q9CQ31 | 323 | ASB11_MOUSE Ankyrin repeat and SOCS box prote... | 121 | 0.31 | 37.7 | 26 | 42 | | | | | | | | | | | | | | | | | | | | | GO:0035556; P:intracellular signal transduction; IEA:InterPro. | 482 | Q5UPJ9 | 627 | YL122_MIMIV Putative ankyrin repeat protein L... | 211 | 0.00002 | 52 | 26 | 43 | | | | | | | | | | | | | | | | | | | | | | 483 | Q8WWX0 | 329 | ASB5_HUMAN Ankyrin repeat and SOCS box protei... | 223 | 0.00006 | 49.7 | 29 | 44 | | | | | | | | | | | | | | | | | | | | | GO:0035556; P:intracellular signal transduction; IEA:InterPro. | 484 | Q8IV38 | 441 | ANKY2_HUMAN Ankyrin repeat and MYND domain-co... | 91 | 0.009 | 42.7 | 34 | 49 | GO:0005929; C:cilium; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 485 | Q9P2G1 | 1089 | AKIB1_HUMAN Ankyrin repeat and IBR domain-con... | 158 | 0.00002 | 52 | 27 | 42 | | | | | | | | | | | GO:0005515; F:protein binding; IPI:IntAct.::GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 486 | Q4FE47 | 462 | XB35_ARATH Putative E3 ubiquitin-protein liga... | 109 | 1.1 | 36.2 | 29 | 44 | | | | | | | | | | | GO:0016874; F:ligase activity; IEA:UniProtKB-KW.::GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 487 | A6NGH8 | 418 | ANR61_HUMAN Ankyrin repeat domain-containing ... | 163 | 0.46 | 37.4 | 27 | 37 | | | | | | | | | | | | | | | | | | | | | | 488 | Q8VHK1 | 1201 | CSKI2_MOUSE Caskin-2 OS=Mus musculus (Mouse).... | 245 | 0.0002 | 48.5 | 24 | 38 | GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. | | | | | | | | | | | | | | | | | | | | | 489 | Q9J5I3 | 700 | V018_FOWPN Putative ankyrin repeat protein FP... | 228 | 0.002 | 45.4 | 22 | 39 | | | | | | | | | | | | | | | | | | | | | | 490 | Q8K0L0 | 634 | ASB2_MOUSE Ankyrin repeat and SOCS box protei... | 69 | 1.6 | 35.8 | 38 | 48 | | | | | | | | | | | | | | | | | | | | | GO:0035556; P:intracellular signal transduction; IEA:InterPro. | 491 | Q9J513 | 747 | V222_FOWPN Putative ankyrin repeat protein FP... | 204 | 5.1 | 34.3 | 28 | 40 | | | | | | | | | | | | | | | | | | | | | | 492 | Q8WXI3 | 467 | ASB10_HUMAN Ankyrin repeat and SOCS box prote... | 84 | 0.026 | 41.6 | 31 | 49 | | | | | | | | | | | | | | | | | | | | | GO:0035556; P:intracellular signal transduction; IEA:InterPro. | 493 | Q9J502 | 512 | V233_FOWPN Putative ankyrin repeat protein FP... | 191 | 0.00003 | 51.2 | 29 | 46 | | | | | | | | | | | | | | | | | | | | | | 494 | Q3TPE9 | 440 | ANKY2_MOUSE Ankyrin repeat and MYND domain-co... | 91 | 0.12 | 39.3 | 32 | 48 | GO:0005929; C:cilium; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | | 495 | O54910 | 364 | IKBE_MOUSE NF-kappa-B inhibitor epsilon OS=Mu... | 76 | 0.005 | 43.5 | 34 | 51 | | | | | | | | | | | | | | | | | | | | | | 496 | Q9BYB0 | 1741 | SHAN3_HUMAN SH3 and multiple ankyrin repeat d... | 216 | 0.00003 | 51.2 | 25 | 43 | GO:0030054; C:cell junction; IEA:UniProtKB-KW.::GO:0060170; C:cilium membrane; ISS:BHF-UCL.::GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.::GO:0014069; C:postsynaptic density; ISS:BHF-UCL.::GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-KW. | | | | | | | | | | GO:0030160; F:GKAP/Homer scaffold activity; ISS:BHF-UCL.::GO:0035255; F:ionotropic glutamate receptor binding; ISS:BHF-UCL.::GO:0008022; F:protein C-terminus binding; ISS:BHF-UCL.::GO:0097110; F:scaffold protein binding; ISS:BHF-UCL.::GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW. | | | | | | | | | | GO:0097113; P:alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering; ISS:BHF-UCL.::GO:0048854; P:brain morphogenesis; ISS:BHF-UCL.::GO:0060997; P:dendritic spine morphogenesis; ISS:BHF-UCL.::GO:0097117; P:guanylate kinase-associated protein clustering; ISS:BHF-UCL.::GO:0007612; P:learning; ISS:BHF-UCL.::GO:0035641; P:locomotory exploration behavior; ISS:BHF-UCL.::GO:0007613; P:memory; ISS:BHF-UCL.::GO:0097114; P:N-methyl-D-aspartate receptor clustering; ISS:BHF-UCL.::GO:0045794; P:negative regulation of cell volume; ISS:BHF-UCL.::GO:0050885; P:neuromuscular process controlling balance; ISS:BHF-UCL.::GO:2000969; P:positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; ISS:BHF-UCL.::GO:2000463; P:positive regulation of excitatory postsynaptic membrane potential; ISS:BHF-UCL.::GO:0048170; P:positive regulation of long-term neuronal synaptic plasticity; ISS:BHF-UCL.::GO:0051835; P:positive regulation of synapse structural plasticity; ISS:BHF-UCL.::GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISS:BHF-UCL.::GO:0097107; P:postsynaptic density assembly; ISS:BHF-UCL.::GO:2000822; P:regulation of behavioral fear response; ISS:BHF-UCL.::GO:1900271; P:regulation of long-term synaptic potentiation; ISS:BHF-UCL.::GO:0035176; P:social behavior; ISS:BHF-UCL.::GO:0021773; P:striatal medium spiny neuron differentiation; ISS:BHF-UCL.::GO:0071625; P:vocalization behavior; ISS:BHF-UCL. | 497 | O00221 | 500 | IKBE_HUMAN NF-kappa-B inhibitor epsilon OS=Ho... | 195 | 0.00003 | 50.8 | 27 | 39 | GO:0005829; C:cytosol; TAS:Reactome. | | | | | | | | | | | | | | | | | | | | GO:0042994; P:cytoplasmic sequestering of transcription factor; TAS:ProtInc. | 498 | P07207 | 2703 | NOTCH_DROME Neurogenic locus Notch protein OS... | 131 | 0.19 | 38.9 | 30 | 44 | GO:0005912; C:adherens junction; IDA:FlyBase.::GO:0005829; C:cytosol; TAS:Reactome.::GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.::GO:0005796; C:Golgi lumen; TAS:Reactome.::GO:0016021; C:integral to membrane; TAS:FlyBase.::GO:0005654; C:nucleoplasm; TAS:Reactome.::GO:0043234; C:protein complex; IPI:FlyBase.::GO:0035003; C:subapical complex; IDA:FlyBase. | | | | | | | | | | GO:0005509; F:calcium ion binding; IEA:InterPro.::GO:0003682; F:chromatin binding; IDA:FlyBase.::GO:0005515; F:protein binding; IPI:UniProtKB.::GO:0004888; F:transmembrane signaling receptor activity; NAS:FlyBase. | | | | | | | | | | GO:0007015; P:actin filament organization; IMP:FlyBase.::GO:0008356; P:asymmetric cell division; TAS:FlyBase.::GO:0007298; P:border follicle cell migration; IMP:FlyBase.::GO:0008407; P:chaeta morphogenesis; IMP:FlyBase.::GO:0042676; P:compound eye cone cell fate commitment; TAS:FlyBase.::GO:0046667; P:compound eye retinal cell programmed cell death; TAS:FlyBase.::GO:0046843; P:dorsal appendage formation; IMP:FlyBase.::GO:0007391; P:dorsal closure; TAS:FlyBase.::GO:0007451; P:dorsal/ventral lineage restriction, imaginal disc; TAS:FlyBase.::GO:0007398; P:ectoderm development; TAS:FlyBase.::GO:0035165; P:embryonic crystal cell differentiation; TAS:FlyBase.::GO:0061331; P:epithelial cell proliferation involved in Malpighian tubule morphogenesis; IMP:FlyBase.::GO:0035153; P:epithelial cell type specification, open tracheal system; IMP:FlyBase.::GO:0035214; P:eye-antennal disc development; IMP:FlyBase.::GO:0007440; P:foregut morphogenesis; IMP:FlyBase.::GO:0030718; P:germ-line stem cell maintenance; IMP:FlyBase.::GO:0030708; P:germarium-derived female germ-line cyst encapsulation; TAS:FlyBase.::GO:0007403; P:glial cell fate determination; IMP:FlyBase.::GO:0008347; P:glial cell migration; IMP:FlyBase.::GO:0035172; P:hemocyte proliferation; IMP:FlyBase.::GO:0007157; P:heterophilic cell-cell adhesion; IMP:FlyBase.::GO:0007446; P:imaginal disc growth; TAS:FlyBase.::GO:0036011; P:imaginal disc-derived leg segmentation; IMP:FlyBase.::GO:0048803; P:imaginal disc-derived male genitalia morphogenesis; IMP:FlyBase.::GO:0008587; P:imaginal disc-derived wing margin morphogenesis; IMP:FlyBase.::GO:0007474; P:imaginal disc-derived wing vein specification; IMP:FlyBase.::GO:0035171; P:lamellocyte differentiation; IMP:FlyBase.::GO:0046331; P:lateral inhibition; NAS:FlyBase.::GO:0007616; P:long-term memory; IMP:FlyBase.::GO:0035170; P:lymph gland crystal cell differentiation; TAS:FlyBase.::GO:0061382; P:Malpighian tubule tip cell differentiation; IMP:FlyBase.::GO:0007498; P:mesoderm development; IMP:FlyBase.::GO:0008045; P:motor axon guidance; IMP:FlyBase.::GO:0007521; P:muscle cell fate determination; IMP:FlyBase.::GO:0045316; P:negative regulation of compound eye photoreceptor development; IMP:FlyBase.::GO:0035157; P:negative regulation of fusion cell fate specification; TAS:FlyBase.::GO:0046329; P:negative regulation of JNK cascade; NAS:FlyBase.::GO:0050768; P:negative regulation of neurogenesis; IMP:FlyBase.::GO:0035155; P:negative regulation of terminal cell fate specification, open tracheal system; TAS:FlyBase.::GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; TAS:FlyBase.::GO:0007400; P:neuroblast fate determination; IDA:FlyBase.::GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.::GO:0007314; P:oocyte anterior/posterior axis specification; TAS:FlyBase.::GO:0030720; P:oocyte localization involved in germarium-derived egg chamber formation; IMP:FlyBase.::GO:0030713; P:ovarian follicle cell stalk formation; IMP:FlyBase.::GO:0007422; P:peripheral nervous system development; IMP:FlyBase.::GO:0008284; P:positive regulation of cell proliferation; IMP:FlyBase.::GO:0045747; P:positive regulation of Notch signaling pathway; IMP:FlyBase.::GO:0045750; P:positive regulation of S phase of mitotic cell cycle; IMP:FlyBase.::GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:FlyBase.::GO:0048052; P:R1/R6 cell differentiation; IMP:FlyBase.::GO:0007464; P:R3/R4 cell fate commitment; NAS:FlyBase.::GO:0045466; P:R7 cell differentiation; IMP:FlyBase.::GO:0045463; P:R8 cell development; TAS:FlyBase.::GO:0007460; P:R8 cell fate commitment; TAS:FlyBase.::GO:0042686; P:regulation of cardioblast cell fate specification; IMP:FlyBase.::GO:0042689; P:regulation of crystal cell differentiation; TAS:FlyBase.::GO:0051489; P:regulation of filopodium assembly; IMP:FlyBase.::GO:0040008; P:regulation of growth; IMP:FlyBase.::GO:0045468; P:regulation of R8 cell spacing in compound eye; NAS:FlyBase.::GO:0009608; P:response to symbiont; IMP:FlyBase.::GO:0016330; P:second mitotic wave involved in compound eye morphogenesis; NAS:FlyBase.::GO:0007519; P:skeletal muscle tissue development; IMP:FlyBase.::GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW.::GO:0007419; P:ventral cord development; NAS:FlyBase.::GO:0048190; P:wing disc dorsal/ventral pattern formation; IMP:FlyBase.::GO:0007473; P:wing disc proximal/distal pattern formation; TAS:FlyBase. | 499 | Q8NI38 | 313 | IKBD_HUMAN NF-kappa-B inhibitor delta OS=Homo... | 190 | 0.003 | 44.3 | 28 | 44 | GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. | | | | | | | | | | | | | | | | | | | | GO:0006954; P:inflammatory response; IEA:UniProtKB-KW. | 500 | Q9J5G9 | 415 | V034_FOWPN Putative ankyrin repeat protein FP... | 261 | 0.5 | 37.4 | 21 | 34 | | | | | | | | | | | | | | | | | | | | | | 501 | Q6TNT2 | 228 | ANR46_DANRE Ankyrin repeat domain-containing ... | 165 | 5.1 | 33.5 | 24 | 37 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW. | | | | | | | | | | | | | | | | | | | | | 502 | Q99466 | 2003 | NOTC4_HUMAN Neurogenic locus notch homolog pr... | 246 | 0.00006 | 50.4 | 28 | 43 | GO:0009986; C:cell surface; IDA:UniProtKB.::GO:0005829; C:cytosol; TAS:Reactome.::GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.::GO:0005576; C:extracellular region; TAS:Reactome.::GO:0000139; C:Golgi membrane; TAS:Reactome.::GO:0005887; C:integral to plasma membrane; TAS:UniProtKB.::GO:0005654; C:nucleoplasm; TAS:Reactome. | | | | | | | | | | GO:0005509; F:calcium ion binding; TAS:UniProtKB.::GO:0046982; F:protein heterodimerization activity; TAS:UniProtKB.::GO:0004872; F:receptor activity; TAS:UniProtKB. | | | | | | | | | | GO:0001709; P:cell fate determination; TAS:UniProtKB.::GO:0009790; P:embryo development; ISS:UniProtKB.::GO:0030097; P:hemopoiesis; TAS:UniProtKB.::GO:0030879; P:mammary gland development; IDA:UniProtKB.::GO:0045602; P:negative regulation of endothelial cell differentiation; ISS:UniProtKB.::GO:0007220; P:Notch receptor processing; TAS:Reactome.::GO:0007219; P:Notch signaling pathway; TAS:Reactome.::GO:0001569; P:patterning of blood vessels; ISS:UniProtKB.::GO:0045893; P:positive regulation of transcription, DNA-dependent; TAS:UniProtKB.::GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome. | 503 | Q9J5I9 | 331 | V012_FOWPN Putative ankyrin repeat protein FP... | 106 | 0.01 | 42.4 | 26 | 45 | | | | | | | | | | | | | | | | | | | | | | 504 | P25799 | 971 | NFKB1_MOUSE Nuclear factor NF-kappa-B p105 su... | 151 | 0.00007 | 50.1 | 32 | 49 | GO:0005829; C:cytosol; IDA:MGI.::GO:0005634; C:nucleus; IDA:MGI. | | | | | | | | | | GO:0005515; F:protein binding; IPI:IntAct.::GO:0042803; F:protein homodimerization activity; IDA:MGI.::GO:0000975; F:regulatory region DNA binding; ISS:UniProtKB.::GO:0043565; F:sequence-specific DNA binding; IDA:MGI.::GO:0003700; F:sequence-specific DNA binding transcription factor activity; IEA:InterPro. | | | | | | | | | | GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.::GO:0048535; P:lymph node development; TAS:MGI.::GO:0001818; P:negative regulation of cytokine production; IMP:BHF-UCL.::GO:0045083; P:negative regulation of interleukin-12 biosynthetic process; IDA:MGI.::GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:UniProtKB.::GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI.::GO:0007165; P:signal transduction; IEA:InterPro.::GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW. | 505 | Q63369 | 522 | NFKB1_RAT Nuclear factor NF-kappa-B p105 subu... | 151 | 0.0004 | 47.4 | 30 | 47 | GO:0005829; C:cytosol; IDA:RGD.::GO:0005634; C:nucleus; IDA:RGD.::GO:0043234; C:protein complex; IDA:RGD. | | | | | | | | | | GO:0003690; F:double-stranded DNA binding; IDA:RGD.::GO:0031072; F:heat shock protein binding; IPI:RGD.::GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:RGD.::GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IDA:RGD. | | | | | | | | | | GO:0006916; P:anti-apoptosis; IMP:RGD.::GO:0009617; P:response to bacterium; IEP:RGD.::GO:0046688; P:response to copper ion; IEP:RGD.::GO:0006979; P:response to oxidative stress; IDA:RGD.::GO:0007165; P:signal transduction; IEA:InterPro.::GO:0006351; P:transcription, DNA-dependent; IEA:UniProtKB-KW. | 506 | Q38998 | 857 | AKT1_ARATH Potassium channel AKT1 OS=Arabidop... | 82 | 0.07 | 40.4 | 30 | 46 | GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.::GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0042802; F:identical protein binding; IPI:IntAct.::GO:0005242; F:inward rectifier potassium channel activity; IDA:TAIR. | | | | | | | | | | GO:0090333; P:regulation of stomatal closure; IMP:TAIR.::GO:0009651; P:response to salt stress; IMP:TAIR.::GO:0009414; P:response to water deprivation; IMP:TAIR.::GO:0048767; P:root hair elongation; IMP:TAIR. | 507 | Q978J0 | 189 | Y1425_THEVO Putative ankyrin repeat protein T... | 164 | 0.02 | 40.4 | 26 | 41 | | | | | | | | | | | | | | | | | | | | | | 508 | Q9SM23 | 338 | ACBP1_ARATH Acyl-CoA-binding domain-containin... | 91 | 0.97 | 36.2 | 27 | 46 | GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.::GO:0005576; C:extracellular region; IEA:UniProtKB-KW.::GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.::GO:0009505; C:plant-type cell wall; IDA:TAIR.::GO:0005886; C:plasma membrane; IDA:TAIR. | | | | | | | | | | GO:0000062; F:fatty-acyl-CoA binding; IDA:TAIR.::GO:0032791; F:lead ion binding; IDA:TAIR.::GO:0070300; F:phosphatidic acid binding; IDA:TAIR. | | | | | | | | | | GO:0006629; P:lipid metabolic process; IMP:TAIR.::GO:0006869; P:lipid transport; TAS:TAIR.::GO:0009409; P:response to cold; IMP:TAIR.::GO:0010288; P:response to lead ion; IEP:UniProtKB. | 509 | Q9Z1E3 | 314 | IKBA_MOUSE NF-kappa-B inhibitor alpha OS=Mus ... | 74 | 0.16 | 38.5 | 38 | 54 | GO:0005829; C:cytosol; IDA:MGI.::GO:0005634; C:nucleus; IDA:MGI. | | | | | | | | | | | | | | | | | | | | GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:MGI.::GO:0045638; P:negative regulation of myeloid cell differentiation; IMP:MGI.::GO:0045746; P:negative regulation of Notch signaling pathway; IMP:MGI.::GO:0070427; P:nucleotide-binding oligomerization domain containing 1 signaling pathway; IDA:MGI.::GO:0070431; P:nucleotide-binding oligomerization domain containing 2 signaling pathway; IDA:MGI.::GO:0000060; P:protein import into nucleus, translocation; IDA:MGI.::GO:0042127; P:regulation of cell proliferation; IDA:MGI.::GO:0043330; P:response to exogenous dsRNA; IDA:MGI.::GO:0032495; P:response to muramyl dipeptide; IDA:MGI.::GO:0034142; P:toll-like receptor 4 signaling pathway; IDA:MGI. | 510 | Q8LSQ2 | 388 | SR43C_ORYSJ Probable signal recognition parti... | 103 | 0.5 | 37.4 | 33 | 42 | GO:0005634; C:nucleus; IEA:InterPro.::GO:0005786; C:signal recognition particle, endoplasmic reticulum targeting; IEA:UniProtKB-KW. | | | | | | | | | | | | | | | | | | | | | 511 | Q0VCS9 | 442 | ANKY2_BOVIN Ankyrin repeat and MYND domain-co... | 91 | 0.011 | 42.4 | 34 | 49 | GO:0005929; C:cilium; IEA:UniProtKB-SubCell. | | | | | | | | | | GO:0008270; F:zinc ion binding; IEA:InterPro. | | | | | | | | | | |